CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
Louisville, Kentucky, United States and 20 other locations
The purpose of this study is to assess the safety, tolerability, and efficacy of CBX-12 in female subjects with platinum resistant or refractory ovarian...
Phase 2
Louisville, Kentucky, United States and 16 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Louisville, Kentucky, United States and 176 other locations
as "study drug". The study is focused on patients who have advanced ovarian cancer.The aim of the study is to see how safe, tolerab...
Phase 2
Louisville, Kentucky, United States and 23 other locations
This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...
Phase 2
Louisville, Kentucky, United States and 81 other locations
Researchers are looking for other ways to treat relapsed high-grade serous ovarian cancer. Relapsed means the cancer came ...
Phase 1, Phase 2
Louisville, Kentucky, United States and 14 other locations
undergoing prospective ophthalmic evaluation with recurrent ovarian cancer (participants with either platinum-sensitive ovarian...
Phase 2
Louisville, Kentucky, United States and 43 other locations
(ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the...
Phase 2
Louisville, Kentucky, United States and 69 other locations
This is a clinical study that has two parts. It is testing a potential new medicine called LY4170156 for people with certain types of ovarian...
Phase 3
Louisville, Kentucky, United States and 38 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Louisville, Kentucky, United States and 237 other locations
Clinical trials
Research sites
Resources
Legal